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Background: Despite current nutritional strategies, premature infants remain at high risk for extrauterine growth
restriction. The use of an exclusive human milk-based diet is associated with decreased incidence of necrotizing
enterocolitis (NEC), but concerns exist about infants achieving adequate growth. The objective of this study was to
evaluate growth velocities and incidence of extrauterine growth restriction in infants ≤ 1250 grams (g) birth weight
(BW) receiving an exclusive human milk-based diet with early and rapid advancement of fortification using a donor
human milk derived fortifier.
Methods: In a single center, prospective observational cohort study, preterm infants weighing ≤ 1250 g BW were
fed an exclusive human milk-based diet until 34 weeks postmenstrual age. Human milk fortification with donor
human milk derived fortifier was started at 60 mL/kg/d and advanced to provide 6 to 8 additional kilocalories per
ounce (or 0.21 to 0.28 kilocalories per gram). Data for growth were compared to historical growth standards and
previous human milk-fed cohorts.
Results: We consecutively evaluated 104 infants with mean gestational age of 27.6 ± 2.0 weeks and BW of 913 ±
181 g (mean ± standard deviation). Weight gain was 24.8 ± 5.4 g/kg/day with length 0.99 ± 0.23 cm/week and
head circumference 0.72 ± 0.14 cm/week. There were 3 medical NEC cases and 1 surgical NEC case. 22 infants
(21%) were small for gestational age at birth. Overall, 45 infants (43%) had extrauterine growth restriction. Weight
velocity was affected by day of fortification (p = 0.005) and day of full feeds (p = 0.02). Our cohort had significantly
greater growth in weight and length compared to previous entirely human milk-fed cohorts.
Conclusions: A feeding protocol for infants ≤ 1250 g BW providing an exclusive human milk-based diet with early
and rapid advancement of fortification leads to growth meeting targeted standards with a low rate of extrauterine
growth restriction. Consistent nutritional policies using this approach may be considered for this population.
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Human milk feeding is associated with substantial benefits
to the health and development of premature infants [1].
The use of an exclusive human milk-based diet for very
low birth weight (VLBW) infants as an alternative to
bovine-based fortification of mother’s own milk or bovine-
based formula has risen dramatically. An exclusive human
milk-based diet is defined as mother’s own milk supple-
mented with pasteurized donor human milk (when
mother’s milk is unavailable) fortified with a donor human* Correspondence: abhair@bcm.edu
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reproduction in any medium, provided the ormilk derived fortifier [2]. Sullivan et al [2] found that an ex-
clusive human milk-based diet in infants ≤ 1250 grams (g)
birth weight (BW) reduced the incidence of necrotizing en-
terocolitis (NEC) by 50% and the rate of surgical NEC by
90%. However, growth failure remains a common concern
in exclusively human milk fed VLBW infants. Some studies
have shown that donor human milk is associated with
slower growth in the early postnatal period [3,4] however;
these studies were limited to unfortified donor human milk
or donor human milk with bovine milk-based fortifier. The
American Academy of Pediatrics policy statement on
breastfeeding and the use of human milk recommends that
all preterm infants receive human milk including donor hu-
man milk if mother’s own milk is unavailable [5].. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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metabolic abnormalities, and poor neurodevelopmental
outcomes [6-8]. Postnatal growth standards are based on
estimated intrauterine growth from historical cohort stud-
ies and post-mortem analyses [4,9]. Despite current strat-
egies aimed at appropriate nutrition, a large proportion of
these infants have postnatal growth failure, also called
extrauterine growth restriction (anthropometric values < 10th
percentile) [8,10,11]. A cohort study of infants < 28 weeks
gestational age showed that growth velocities greater than
current guidelines are needed to ensure that infants maintain
their birth weight percentile on the growth curve and avoid
extrauterine growth restriction [12]. Recommended enteral
nutrient intakes per Tsang guidelines [13] for VLBW infants
are 110–130 kilocalories per kilogram per day (kcal/kg/d)
with 3.4-4.2 grams per kilogram per day (g/kg/d) of pro-
tein. For extremely low birth weight infants, recom-
mended enteral nutrient intakes are 130–150 kcal/kg/d
with 3.8-4.4 g/kg/d of protein [13]. The ESPGHAN Com-
mittee on Nutrition recommends 110–135 kcal/kg/d with
4.0-4.5 g/kg/d of protein for preterm infants receiving en-
teral nutrition [14]. Adequate growth is key to ensuring
improved neurodevelopmental and other outcomes. For
infants < 1000 g BW, Ehrenkranz et al [15] found that as
the rate of weight gain and head circumference (HC) in-
creased, there was decreased incidence of cerebral palsy
and poor neurodevelopmental scores at 18 to 22 months’
corrected age.
Because of the potential benefits of using an exclusive
human milk-based diet, but remaining uncertainty about
growth, we chose to evaluate the growth in all of our in-
fants ≤ 1250 g BW receiving this diet. In this single center,
prospective observational cohort study, we hypothesized
that a feeding protocol providing an exclusive human
milk-based diet with early and rapid advancement of forti-
fication using a donor human milk derived fortifier would
meet growth standards in infants ≤ 1250 g BW and lead to
decreased extrauterine growth restriction.
Methods
Infants were consecutively followed in this single center
prospective cohort study from August 2010 to December
2011. Inclusion criteria were: premature infants <37 weeks
gestation, BW ≤ 1250 g, admitted within 48 hours of birth,
receiving an exclusive human milk-based diet, and achieve-
ment of full enteral feedings by 4 weeks of age. Infants
were excluded who died within the first week of life and
those who had major congenital anomalies. Infants were
followed from birth until discharge and data were pro-
spectively collected for growth and nutrition using pre-
study defined variables and definitions.
As approved by the Institutional Review Board of Baylor
College of Medicine and Affiliated Hospitals, consent was
waived for this observational study. It was registered withclinicaltrials.gov (reg. # NCT01204983). Our primary out-
come was to evaluate the nutritional management inclu-
ding growth analysis for infants receiving an exclusive
human milk-based diet with a donor human milk derived
fortifier.
Standardized feeding protocol
Infants were fed a standardized feeding protocol as toler-
ated providing an exclusive human milk-based diet. The
protocol was maintained throughout the study period and
was under twice weekly guidance by a neonatal dietitian.
Infants received mother’s own milk supplemented with
pasteurized donor human milk when mother’s milk was
unavailable. Donor human milk was obtained from a mem-
ber milk bank of the Human Milk Banking Association of
America. Our hospital has a human milk preparation area
with dedicated milk bank technicians that follow evidence-
based protocols and American Dietetic Association stan-
dards specific to milk collection, transportation, storage,
preparation, and fortification.
Enteral feeding was started within the first 24 hours of
life if medically feasible with trophic feeds of 20 milliliters
per kilogram per day (mL/kg/d) for 3 days. While enteral
feeding was advanced, goal parenteral nutrition intake as
per protocol provided 110 kcal/kg/d with 3.5 g/kg/d of
protein and 3 g/kg/d of fat as Intralipid 20% (Baxter).
Intralipid was discontinued once feeds were at 80 ml/kg/d
and parenteral nutrition was discontinued once volume
fell below 50 ml/kg/d or feeds were at 100 to 120 ml/kg/d.
Feeds were advanced by 20 mL/kg/d to reach a goal of 140
to 150 mL/kg/d. Human milk was fortified with pasteurized
donor human milk derived fortifier, Prolact+H2MF®
(Prolacta Bioscience, Industry, CA [16]). Human milk
fortification occurred at 60 ml/kg/d (HMF 60) to provide an
additional 4 kilocalories per ounce (kcal/oz) which is equal
to an additional 0.14 kilocalories per gram (kcal/g) and then
an additional 6 kcal/oz (0.21 kcal/g) at 100 to 120 ml/kg/day.
Assuming infants received human milk at 20 kcal/oz
(0.67 kcal/g) with 0.9 g/dL of protein based on reference
values for mature milk [17] and full feeds at a volume of
150 ml/kg/day with fortification with a donor human milk
derived fortifier of an additional 6 kcal/oz (0.21 kcal/g), then
infants received a total of 130 kcal/kg/day with 3.6 g/kg/day
of protein. Once full enteral feedings were established, if
weight gain did not reach 15 g/kg/d within a week, as per
protocol, fortification was advanced to provide an additional
8 kcal/oz (0.28 kcal/g) or 140 kcal/kg/day and 4.4 g/kg/day
of protein. The maximum amount of fortification pro-
vided to infants was an extra 10 kcal/oz (0.35 kcal/g) or
150 kcal/kg/day and 5.25 g/kg/day of protein. Infants re-
ceived this diet until approximately 34 weeks postmens-
trual age (PMA) and were then transitioned over a period
of five days to a specialized formula or bovine milk-based
fortifier.
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Weight was recorded daily. Length and HC were recorded
weekly. Bedside nurses obtained weight using digital baby
scales or Giraffe® OmniBed scales (GE Healthcare, Finland).
Measurements for length and HC were obtained using a
length board and tape measure, respectively. Growth ve-
locities from birth to discharge, were compared to pre-
study defined growth standards which were weight gain
15 g/kg/day, length 1.0 centimeters per week (cm/week),
and HC 0.7 cm/week based on historical cohort studies
[4,9]. Birth and discharge or 40 weeks PMA (if discharged
after 40 weeks PMA) anthropometric data were compared
to intrauterine-based growth curves published by Olsen
et al [18].
Study outcomes included growth velocity (weight,
length and HC), number of days to full feeds (tolerating
fortified feeds of 140 ml/kg/d), total parenteral nutrition
(TPN) days, NEC, spontaneous intestinal perforation,
late onset sepsis, ileus associated with sepsis, patent
ductus arteriosus, intraventricular hemorrhage (IVH),
bronchopulmonary dysplasia, length of stay, discharge
weight and number of infants small for gestational age
(SGA) at discharge or 40 weeks PMA. We defined NEC
as Stage II NEC or greater using modified Bell’s criteria
[19]. The presence of pneumatosis on abdominal radio-
graph was read by a pediatric radiologist. Medical NEC
was defined as Bell’s Stage II disease or greater while
surgical NEC was defined as NEC requiring surgery du-
ring the acute care period. Late onset sepsis was defined
as culture positive sepsis after 3 days of age associated
with clinical symptoms of sepsis. IVH on head ultra-
sound imaging was classified per Papile et al. with severe
IVH defined as grade III or grade IV [20]. Bronchopul-
monary dysplasia was defined as oxygen dependence at
36 weeks PMA. Small for gestational age (SGA) was de-
fined as a weight < 10th percentile on the Olsen growth
curve [18]. Appropriate for gestational age (AGA) was
defined as a weight ≥ 10th percentile but < 90th percen-
tile on the Olsen et al. growth data [18].
Our cohort data were then compared to previous hu-
man milk fed cohorts. Our cohort received a feeding
protocol that rapidly advanced human milk fortification as
compared to the fortification strategy used in the Sullivan
et al [2] study. Since the use of an exclusive human milk-
based diet with a donor human milk derived fortifier is a
relatively new feeding strategy for preterm infants, we
chose to compare our cohort to two cohorts that had re-
ceived this diet and a cohort that received what is consid-
ered a routine diet for preterm infants. The three previous
human milk fed cohorts from the Sullivan et al [2] study
are listed as the following: mother’s own milk (supple-
mented with pasteurized donor human milk) fortified with
donor human milk derived fortifier at 40 ml/kg/d (HMF
40), mother’s own milk (supplemented with pasteurizeddonor human milk) fortified with donor human milk de-
rived fortifier at 100 ml/kg/d (HMF 100), and mother’s
own milk fortified with bovine milk-based fortifier at 100
ml/kg/d or preterm formula if mother’s own milk unavail-
able (Bovine HMF or formula). The donor human milk
derived fortifier used in the HMF 40 and HMF 100 cohort
provided an additional 4 kcal/oz (0.14 kcal/g) which would
provide an estimated 120 kcal/kg/day and 2.85 g/kg/day of
protein if infants were assumed to receive mature human
milk at a volume of 150 ml/kg/day. The bovine milk-based
fortifiers used in the Bovine HMF cohort provided an add-
itional 4 kcal/oz (0.14 kcal/g) and an estimated 120 kcal/
kg/day with 2.9 or 3.9 g/kg/day protein depending on
which bovine fortifier was used.
Statistical analyses
Relationships among groups were evaluated using general
linear modeling in which growth parameters were the pri-
mary outcomes. Paired t-test was used to compare birth
and discharge percentiles of infants and regression analysis
was used to compare relationships between growth veloci-
ties and change in these percentiles. Additionally, compa-
risons between our cohort and previous human milk
fed cohorts were performed as follows: Kruskal-Wallis
test for baseline quantitative outcomes, chi-squared test
for baseline qualitative outcomes, Kaplan-Meier method
with log rank test for median number of TPN days,
and Kruskal-Wallis test for comparison of growth ve-
locities with pairwise comparisons using Fisher’s LSD
test. Statistical significance was defined as p <0.05. Analyses
were completed using SPSS 19.0 (SPSS Inc., Chicago, IL).
All data are mean ± standard deviation unless otherwise
noted.
Results
We consecutively observed 104 infants (Figure 1) with
demographics and study outcomes presented in Tables
(Table 1) (Table 2). Mean weight gain was 24.8 ± 5.4 g/kg/d
which exceeded the targeted growth standard of 15 g/kg/d
(Figure 2). In the cohort, 98% of infants had a weight
velocity from birth to discharge greater than the goal of
15 g/kg/day with 81% of infants achieving > 20 g/kg/day.
Mean length gain was 0.99 ± 0.23 cm/wk which met the
targeted standard of 1.0 cm/wk and 50% of infants had a
length velocity greater than this target (Figure 2). Mean
gain in HC was 0.72 ± 0.14 cm/wk which met the targeted
standard and 61% of infants had a HC velocity greater than
this target (Figure 2). When evaluating growth velocities at
40 weeks PMA (or before if discharged prior to 40 weeks
PMA), which gave a mean PMA of 38.5 ± 1.8 weeks, mean
weight gain was 24.4 ± 5.5 g/kg/day, length gain was 1.01 ±
0.2 cm/wk, and HC gain was 0.75 ± 0.14 cm/wk.
Forty-nine infants (47%) received > 90% mother’s own
milk. At the time of discharge home, 7 infants (7%) were
Figure 1 104 infants ≤ 1250 g BW receiving an exclusive
human milk-based diet were prospectively followed.
Table 2 Outcomes for infants ≤ 1250 g BW receiving an
exclusive human milk-based diet
n = 104
Weight gain, g/kg/d 24.8 ± 5.4*
Length, cm/wk 0.99 ± 0.23
Head circumference, cm/wk 0.72 ± 0.14
Days to regain birth weight 8.4 ± 4.0
Days to full feeds 14 (12,19)†
Days to fortification of feeds 10 (8,14)
Volume at which feeds were fortified, ml/kg/d 80 (60, 90)
Parenteral nutrition days 13 (10, 19)
Transition to bovine products, wks PMA 36 ± 1.5
Necrotizing enterocolitis Medical, n (%) 3 (3)
Surgical, n (%) 1 (1)
Spontaneous intestinal perforation, n (%) 2 (2)
Late onset sepsis, n (%) 14 (13)
Patent ductus arteriosus, n (%) 49 (47)
No IVH, n (%) 78 (75)
IVH: Grade III or IV, n (%) 5 (5)
Bronchopulmonary dysplasia, n (%) 46 (44)
Weight at discharge, g 2795 (2247, 3155)
Length of stay, d 82 (68, 106)
Post-menstrual age at discharge, wks 40.8 ± 6.0
SGA at birth, n (%) 22 (21)
SGA at discharge or 40 weeks PMA, n (%) 45 (43)
*Mean ± SD, †Median (25th, 75th percentile).
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receiving any human milk. Weight velocity from birth
to discharge was significantly affected by the day of for-
tification of feeds (p = 0.005), days to reach full enteral
feeds (p = 0.02), and BW (p < 0.001) but not gender or
race. In addition, the change in percentile on the growth
curve from BW to discharge weight was significantly af-
fected by the weight gain (p = 0.04). The number of
days to reach full enteral feeds was affected by the pre-
sence of a PDA (p < 0.001) as well as NEC, intestinal
perforation, or ileus associated with sepsis (p < 0.001)
but not by gestational age or gender. Increased days onTable 1 Demographics for infants ≤ 1250 g BW receiving
an exclusive human milk-based diet
n = 104
Birth weight, g 913 ± 182*
Gestational age, wks 27.6 ± 2.0
Male, n (%) 49 (47)




Birth length, cm 34.4 ± 2.6
Birth head circumference, cm 24.2 ± 1.8
APGAR 5 minute 7 ± 2
Inborn, n (%) 59 (57)
Antenatal steroids, n (%) 77 (74)
*Mean ± SD.TPN was associated with an increased risk of late onset
sepsis (p < 0.001).
Although it is not routine practice at our institution,
thirteen infants (13%) received additional supplementa-
tion secondary to severe growth failure: 5 received donor
human milk that was 22 kcal/oz (0.73 kcal/g), 3 received
expressed human milk obtained from the infant’s motherFigure 2 Growth velocities from birth to discharge.
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Nutrition, http://www.nestle-nutrition.com), 2 received
Polycose® (Abbott Nutrition, http://abbottnutrition.com), 1
received corn oil, 1 received safflower oil, and 1 received
MCT oil. These infants were mostly fluid restricted and on
diuretics for significant bronchopulmonary dysplasia. Add-
itional supplementation did not significantly affect weight
gain (p = 0.23), length gain (p = 0.47) or head circumfer-
ence gain (p = 0.16) from birth to discharge.
Three infants received insulin in the first week of life for
hyperglycemia and 10 infants received postnatal steroids.
There were 11 sets of twins in the cohort. There were an
additional 13 infants that were twins but only one twin
met weight criteria for the study. There was one set of
triplets and 2 of 3 infants were followed. Weight gain from
birth to discharge was not affected by whether the infant
was a twin or multiple.
Twenty-two infants (21%) were SGA at birth and 100%
of these infants were SGA at discharge or 40 weeks PMA.
Of the eighty-two (79%) infants born AGA, only 23 (22%)
infants were categorized as SGA at discharge or 40 weeks
PMA. Overall, forty-five infants (43%) were SGA at dis-
charge or 40 weeks PMA (mean PMA was 38.5 ± 1.8
weeks for this comparison) based on recently available
intrauterine-based growth curves [18]. When comparing
AGA to SGA infants, there was no difference in growth
velocities for weight, length, and HC. When comparing
the change in percentile on growth curves for all infants
from birth to discharge, there was a significant difference
for weight, length and head circumference (p < 0.001).
Weight gain (p < 0.001, R2 = 0.21), length gain (p < 0.001,
R2 = 0.13) and head circumference gain (p < 0.001, R2 =
0.08) were negatively correlated with change in percentile
from birth to discharge. As gain increased, there was less
difference in birth and discharge percentiles.
For the 22 infants that were SGA at birth, discharge
weight percentile was affected by birth weight (p = 0.01)
and birth weight percentile (p < 0.001) but not weight
gain (g/kg/d) from birth to discharge, when feeds were
fortified, or days to full enteral feeds. For the 82 AGA
infants, discharge weight percentile was affected by birth
weight (p = 0.003), birth weight percentile (p = 0.001),
weight gain (g/kg/d) from birth to discharge (p = 0.010)
and when feeds were fortified (p = 0.04) but not days to
full enteral feeds (p = 0.32).
There were three cases of medical NEC and one surgical
NEC case. All infants were AGA at birth. Two cases of
medical NEC occurred at 29 and 30 weeks PMA while in-
fants were receiving an exclusive human milk-based diet.
The third case of medical NEC occurred at 37 weeks
PMA while the infant was receiving all formula feeds. The
case of surgical NEC occurred at 31 weeks PMA while the
infant was receiving an exclusive human milk-based diet.
The infant required exploratory laparotomy a week afterinitial diagnosis and underwent a subtotal colectomy and
end-ileostomy.
Our cohort data were then compared to three previous
human milk fed cohorts (Table 3). Baseline variables were
similar between the 4 groups except for a significant dif-
ference between race (p < 0.001) consistent with our single
site cohort compared to a multi-center study. When com-
paring growth rates of our cohort to previous human milk
fed cohorts, our cohort had significantly greater growth in
weight (p < 0.001) and length (p = 0.008) but no difference
in head circumference (p = 0.84) (Table 3). Pairwise com-
parisons were significant with global 5% significance be-
tween the 4 groups for the following: weight gain for our
cohort was significantly higher than each of the other 3
groups and the Bovine HMF or Formula group was sig-
nificantly higher than HMF 100 group; length growth was
significantly higher in our cohort than HMF 100 group.
There were no significant pairwise differences for head cir-
cumference growth between the groups. When comparing
feeding data, our cohort reached full feeds sooner, had less
TPN days, and had earlier fortification of feeds (Table 3).
Discussion
In 104 premature infants receiving a feeding protocol pro-
viding an exclusive human milk-based diet, we demon-
strated that weight gain exceeded targeted growth
standards and length and HC gain met targeted standards
[4,9]. We speculate that the early introduction and rapid
advancement of human milk fortification in our protocol
led to achievement of adequate growth rates. As evidence
for this, we found that weight gain from birth to discharge
was significantly affected by the day of fortification of
feeds and days to reach full enteral feeds. With rapid ad-
vancement of human milk fortification using a donor hu-
man milk derived fortifier, infants received an additional 6
kcal/oz (0.21 kcal/g) prior to achievement of full feeds.
Once infants achieved full feeds, they received a minimum
estimated caloric intake of 130 kcal/kg/d with 3.6 g/kg/d
of protein but often received 140 kcal/kg/d with 4.4 g/kg/
d of protein if growth did not meet targeted standards.
This lead to increased caloric and protein intake as com-
pared to other feeding strategies [2] and lead to improved
growth which is supported by literature suggesting im-
proved outcomes with early nutrition [15,21]. In addition
to meeting targeted growth, infants achieved full feeds
earlier and had less TPN days as compared to other hu-
man milk fed cohorts. Although not statistically signifi-
cant, earlier initiation of feeds in our cohort may have
contributed to improvement in growth as well. There was
a low rate of NEC observed with this feeding strategy.
When comparing growth rates of our cohort to previous
human milk fed cohorts, our cohort had significantly
greater growth in weight and length but no difference in
head circumference. This study provides data showing
Table 3 Comparison of current study cohort and other human milk fed cohorts
Current study human milk +
HMF 60* (n = 104)
Human milk +
HMF 40† (n = 71)
Human milk +
HMF 100† (n = 67)
Bovine HMF or
formula† (n = 69)
p-value
Birth weight, g 913 ± 182‡ 909 ± 193 945 ± 202 922 ± 197 0.67
Birth length, cm 34.4 ± 2.6 34.9 ± 3.2 35.2 ± 3.1 35.0 ± 2.9 0.16
Birth head circumference, cm 24.2 ± 1.8 24.6 ± 1.9 24.6 ± 2.1 24.7 ± 1.6 0.35
Gestational age, wks 27.6 ± 2.0 27.1 ± 2.3 27.2 ± 2.2 27.3 ± 2.0 0.70
APGAR 5 minute 7 ± 2 8 ± 1 7 ± 2 7 ± 2 0.06
Male/Female, n (%) 49/55 (47/53) 25/46 (35/65) 32/35 (48/52) 36/33 (52/48) 0.21
Race: White, n (%) 28 (27) 37 (52) 33 (49) 34 (49) 0.001
Black 40 (38) 17 (24) 20 (30) 10 (14)
Hispanic 24 (23) 15 (21) 13 (19) 22 (32)
Other 12 (12) 2 (3) 1 (2) 2 (3)
Antenatal steroids, n (%) 77 (74) 51 (72) 56 (83) 53 (77) 0.39
Weight gain (g/kg/d) 24.8 ± 5.4 14.6 ± 4.5 14.0 ± 2.9 16.0 ± 7.8 <0.001
Length (cm/wk) 0.99 ± 0.23 0.93 ± 0.53 0.86 ± 0.44 0.93 ± 0.35 0.008
Head circumference (cm/wk) 0.72 ± 0.14 0.72 ± 0.22 0.71 ± 0.22 0.74 ± 0.22 0.84
Days to full feeds 18.2 ± 10.6 24.4 ± 12.7 26.5 ± 18.0 25.0 ± 13.5 <0.001
Day of life feeds initiated 3.3 ± 2.9 5.6 ± 6.6 4.3 ± 3.9 4.7 ± 4.8 0.56
Day of life feeds fortified 13.0 ± 8.3 14.1 ± 9.0 21.0 ± 14.9 18.4 ± 9.2 <0.001
TPN days 13 (10, 19)§ 20 (11,33) 20 (13,34) 22 (13,34) <0.001
% of human milk that was mother’s own
milk
65.7 ± 40.3 70.6 ± 40.9 67.5 ± 37.2 N/A 0.046
*mother’s own milk or donor human milk fortified with donor human milk derived fortifier at 60 ml/kg/d, †Sullivan et. al, J Peds, 2010, ‡Mean ± SD, §Median
(25th, 75th percentile).
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growth standards when receiving an exclusive human
milk-based diet. It is important to note that infants were
fed differently in our cohort as stated above with early and
rapid advancement of fortification of feeds. We speculate
that this fortification strategy contributed to the mean
weight gain of about 25 g/kg/d.
All infants who were SGA at birth remained so at dis-
charge which is consistent with literature that there is a
greater incidence of postnatal growth failure in SGA pre-
mature infants [8,22]. Discharge weight percentile for
SGA infants was affected by birth weight and weight per-
centile at birth but not weight gain, when feeds were forti-
fied, or days to full enteral feeds. When comparing SGA
to AGA infants, there was no difference in growth veloci-
ties. This suggests that the growth of SGA infants is af-
fected by additional factors unrelated to fortification and
obtainment of full feeds as compared to AGA infant.
Despite current nutritional strategies aimed at early ap-
propriate nutrition, a large proportion of preterm infants
have extrauterine growth restriction [8,10,11,22]. Out-
comes for very low birth weight infants from January 1995
to December 1996 were reported by The National Insti-
tute for Child and Human Development Neonatal Re-
search Network for 4,438 infants weighing 501 to 1500 gat birth [22]. In this cohort, 22% of infants were SGA at
birth and 97% of them had growth failure at 36 weeks cor-
rected age [22]. For infants 501 to 1,000 g at birth, 17%
were SGA at birth with 99% growth failure at 36 weeks cor-
rected age [22]. Another large study by Clark et al., which
was a database review of growth data on 24,371 premature
neonates born between 23 and 34 weeks’ gestational age,
found that the incidence of extrauterine growth restriction
at discharge was 28% and the incidence increased with
decreasing gestational age and birth weight [11].
In our study, infants’ weight gain exceeded targeted
standards while receiving a feeding protocol providing
early and rapid advancement of fortification of human
milk; however 43% of infants had extrauterine growth
restriction at discharge or 40 weeks PMA. This is an im-
provement from most previous literature, but further
improvement is needed as growth during the postnatal
period is critical. Ehrenkranz et al. reported that as the
rate of weight gain and HC increased in extremely low
birth weight infants, the incidence of cerebral palsy and
poor neurodevelopmental scores decreased significantly
at 18 to 22 months’ corrected age [15].
One study of infants < 28 weeks gestation showed that
although infants met the current standard weight gain of
15 g/kg/d, infants still had extrauterine growth restriction
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with 98% of infants achieving a weight gain greater than
15 g/kg/day and despite this, 43% had postnatal growth
failure. We evaluated percentiles for weight, length, and
head circumference at discharge or 40 weeks PMA as in-
fants were plotted and compared to growth curves pub-
lished by Olsen et al [18]. We used these growth curves
for comparison because they are intrauterine growth
curves based on large and racially diverse United States
birth data from 22 to 42 weeks gestational age [18]. When
excluding infants born SGA in the cohort, the rate of
AGA infants with a weight < 10th percentile at discharge
or 40 weeks PMA was 22%. When comparing the change
in percentile from birth to discharge for all infants, there
was a significant difference for weight, length and head
circumference. As growth increased, there was less diffe-
rence in birth and discharge percentiles suggesting that
improved growth helps maintain growth percentile as
reported in the literature [12].
One study limitation was that by design, we only eval-
uated those infants who were able to achieve full feeds
and therefore excluded a small number of infants. Two
infants did not achieve full feeds by 3 months of age. Of
the 13 infants that died, 9 (69%) died within the first two
week of age. Although this exclusion may have led to a
study population that may have had less severity of ill-
ness, the majority of infants were excluded (14 infants)
because they died within the first two weeks of age or
did not receive the feeding protocol. One of the
strengths of this study was that infants were fed a stan-
dardized feeding protocol as tolerated using the same
defined diet of an exclusive human milk-based diet with
a donor human milk derived fortifier.
Conclusions
A feeding protocol for infants ≤ 1250 g BW providing
an exclusive human milk-based diet with early and rapid
advancement of fortification was associated with weight
gain exceeding targeted standards and with length and
HC growth meeting targeted standards. Infants had a
lower rate of extrauterine growth restriction compared to
historical literature but further improvement is needed.
Consistent nutritional policies using this approach may be
considered for this population.
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